Roche - Biotech, Pharma and Life Science Channel
Roche is the 5th largest pharmaceutical company in the world, based on annual sales, which were recorded at $36,017m in 2009.
The pharmaceutical products of Roche are major players in the following areas of medical research and development and treatment; cancer, transplantation, autoimmune diseases, inflammatory diseases, virology, metabolic disorders and diseases of the central nervous system.
In addition to this Roche also has a n interest in diagnostics and their development, specifically immuno- assays, molecular diagnostics and clinical chemistry.
For more than 110 years Roche has played a pioneering role in healthcare, and its portfolio is continuing to grow in size and value.
Source; BioPortfolio.com and Roche.com
Add the Roche News Channel to your RSS reader;
Follow the Roche Twitter feed;
News Articles
Blood Banking Market Trends and Opportunities for Suppliers
DALLAS, May 17, 2013 /PRNewswire-iReach/ -- ReportsnReports.com offers new blood banking market research reports for UK, France, Germany, Italy, Spain, US and Japan covering information on industry ou...
Leading provider of mail-order diabetic testing supplies becomes one of only 18 companies in nation authorized by CMS to serve Medicare patients...
Roche today announced the first results from CLL11, a phase III study of the investigational medicine GA101 which is being conducted in collaboration with the German CLL Study Group (GCLLSG).
New Roche Award for Antibody-based Cancer Therapy Research
PENZBERG, Germany, May 15, 2013 /PRNewswire/ -- Researchers from academia throughout Europe are invited to participate In a newly created award, pRED`s Discovery Oncology unit of Roche (SIX: RO, ROG...
Roche to present important new data reflecting broad cancer pipeline at ASCO
First phase III data on obinutuzumab (GA101) in one of the most commonly diagnosed blood cancers; Early stage data on investigational anti-PDL1 immunotherapy
– Tarceva is the First Personalized Medicine Approved for the Initial Treatment of People with EGFR Mutation-Positive Advanced Non-Small Cell Lung Cancer in the United States â€...
Alliance Boots builds up interest in China - comment from The Economist Intelligence Unit
“Alliance Boots is building up its interests in China's pharmacy sector, in anticipation of growth and consolidation in the market. The Economist Intelligence Unit expects pharma sales (in...
ImmunoGen, Inc. Announces Webcast of Presentation at Upcoming Investor Conference
ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops anticancer therapeutics using its Targeted Antibody Payload (TAP) antibody-drug conjugate (ADC) techno...
FDA approves ACTEMRA for children living with a rare form of arthritis
Roche announced today that the U.S. Food and Drug Administration (FDA) has approved ACTEMRA (tocilizumab) for the treatment of polyarticular juvenile idiopathic arthritis (PJIA). The medicine can be u...
Exosome Diagnostics Names Kapil Dhingra Chairman of the Board of Directors
NEW YORK, April 29, 2013 /PRNewswire/ -- Exosome Diagnostics, a leading developer of biofluid-based molecular diagnostic tests for use in personalized medicine, today announced that Kapil Dhingra, M.D...
Events
12th Annual Biological Production Forum 2013
Improving your biological production performance to overcome challenges in the biomanufacturing industry
Companies
Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world’s largest biotech company,...
Founded more than 35 years ago, Genentech is a leading biotechnology company that discovers, develops, manufactures and commercializes medicines to treat patients with serious or life-threatening me...
Opsona is a leading immunology drug development company, focused on novel therapeutic approaches to key targets of the innate immune system associated with a wide range of majo...
Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world’s largest...
Aileron Therapeutics has defined a new class of drugs called Stapled Peptides. The company’s proprietary Stapled Peptides platform is a breakthrough approach to creating drug...
MDxHealth is a leading molecular diagnostics company that develops and commercializes oncology-based molecular diagnostic testing for personalized medicine. The company’s tes...
Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world’s largest...
Nil
Berlin-based NOXXON Pharma AG is a clinical stage biotechnology company focusing on the development of Spiegelmers® for the treatment of inflammatory diseases and hematological...
Exelixis, Inc. is a development-stage biotechnology company dedicated to the discovery and development of novel small molecule therapeutics for the treatment of cancer and other s...
Clinical Trials
Erythropoietin Therapy for Subarachnoid Hemorrhage
ABSTRACT: Delayed ischemic deficits (DID) and strokes caused by low cerebral blood flow (CBF) are major sources of poor outcome following aneurysmal subarachnoid hemorrhage (SAH). DID are...
This study will compare the safety, tolerability and efficacy of aleglitazar and Actos® in patients with type 2 diabetes and symptomatic NYHA class II heart failure. Eligible patients wil...
Hepatitis C infects as many as 300,000 Canadians. Up to 25% of those infected will develop cirrhosis and be at risk for liver failure and liver cancer. Cirrhosis caused by hepatitis C is t...
The Effect of Xenical on Weight and Risk Factors
The purpose of this study is to determine the effect of using the weight loss medication Xenical (generic name - orlistat) on weight loss and change in heart disease risk factors in patien...
To compare the proportion of patients whose plasma HIV-1 RNA level falls and remains below the limit of quantification by the Roche Amplicor Monitor (400 copies/ml)[AS PER AMENDMENT 8/4/98...
Phase I Oral mTOR Inhibitor RAD001 in Combo w/ Capecitabine for Metastatic Breast
In order to improve the survival of metastatic breast patients, it is important to investigate the use of novel therapeutic agents combined with known active agents in the treatment of bre...
This study will evaluate the safety and efficacy of FTY720 versus mycophenolate mofetil (MMF, Roche brand) combined with cyclosporine and corticosteroids in patients receiving a kidney tra...
Hemoglobin Kinetics in Response to Mircera® in Patients With Acute Myocardial Infarction
Hypothesis: Based on available pharmacokinetic data from healthy volunteers we hypothesize that the administration of a cumulative dose of 210μg of the continuous erythropoietin receptor...
XAD - Xelox (Capecitabine + Oxaliplatin) + Bevacizumab + Dasatinib
The primary purpose of this study is to find the highest tolerated dose of the study drugs: capecitabine, oxaliplatin, bevacizumab, and dasatinib given in combination to subjects with adva...
Population Pharmacokinetics/Pharmacodynamics (PK/PD) of Microemulsion Propofol in Healthy Volunteers
AquafolTM (Daewon Pharmaceutical Co., Ltd., Seoul, Korea) is a microemulsion propofol that has been developed for eliminating lipid solvent-related adverse events of long chain triglycerid...
PubMed Articles
PURPOSE: To verify the robustness and fundamental value of Atomic Force Microscopy (AFM) and AFM-based assays to rapidly examine the molecular homogeneity and physical stability of amorphous solid dis...
Shrinkage estimation in two-stage adaptive designs with midtrial treatment selection.
We consider the problem of estimation in adaptive two-stage designs with selection of a single treatment arm at an interim analysis. It is well known that the standard maximum-likelihood estimator of...
Damage of target cells by cytotoxicity, either mediated by specific lymphocytes or via antibody-dependent reactions, may play a decisive role in causing the CNS lesions seen in Multiple Sclerosis. Rel...
Polyether-based polyurethanes (PBP) are extremely problematic polymers due to their long persistence in the environment. Moreover, the assessment of PBP biodegradation remains biased due to the inabil...
Sustainable management of sea mullet (Mugil cephalus) fisheries needs to account for recent observations of regional-scale differentiation. Population genetic analysis is sought to assess the situatio...
BACKGROUND: Several comparison studies showed that the Ultrio assay (Novartis Diagnostics) used in individual-donation nucleic acid amplification testing (ID-NAT) format was as sensitive as the TaqScr...
The effect of raw materials on product yield and quality in bio-manufacturing is considerable and often poorly understood. Here we describe the capabilities of NIR (near-infrared) and two dimensional...
Deal watch: Chiasma and Roche partner in oral peptide drug delivery.
As part of the DNA Sequencing Research Group of the Association of Biomolecular Resource Facilities, we have tested the reproducibility of the Roche/454 GS-FLX Titanium System at five core facilities....
Intrinsic bias and public rearrangements in the human immunoglobulin Vλ light chain repertoire.
The immunoglobulin lambda (IGL) repertoires from two unrelated human blood samples, three NOD-scid-IL2Rγ(null) mice engrafted with human hematopoietic stem cells and two pairs of monozygotic twin blo...
Videos
Sébastien Tellier - Roche
J'ai longtemps passé mes vacances ici à Biarritz. Si je voulais séduire, je passerais cette chanson, une version européenne, française, de l'envoûtement se...
